1. A Novel Noninvasive Program for Staging Liver Fibrosis in Untreated Patients With Chronic Hepatitis B. Issue 5 (22nd May 2019) Authors: Chen, Yan; Wang, Yongji; Chen, Yongping; Yu, Zujiang; Chi, Xiaoling; Hu, Ke-Qin; Li, Qin; Tan, Lin; Xiang, Dedong; Shang, Qinghua; Lei, Chunliang; Chen, Liang; Hu, Xiaoyu; Wang, Jing; Liu, Huabao; Lu, Wei; Chi, Weilai; Dong, Zheng; Wang, Xiaodong; Li, Zhiqin Journal: Clinical and translational gastroenterology Issue: Volume 10:Issue 5(2019) Page Start: e00033 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. DNA methyltransferase mediates the hypermethylation of the microRNA 34a promoter and enhances the resistance of patient-derived pancreatic cancer cells to molecular targeting agents. (October 2020) Authors: Ma, Yan; Chai, Ningli; Jiang, Qiyu; Chang, Zhengyao; Chai, Yantao; Li, Xiaojuan; Sun, Huiwei; Hou, Jun; Linghu, Enqiang Journal: Pharmacological research Issue: Volume 160(2020) Page Start: Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Effect of the hyaluronic acid‐poloxamer hydrogel on skin‐wound healing: in vitro and in vivo studies. Issue 2 (30th April 2019) Authors: Li, Xiaojuan; Li, Aimin; Feng, Fan; Jiang, Qiyu; Sun, Huiwei; Chai, Yantao; Yang, Ruichuang; Wang, Zhijie; Hou, Jun; Li, Ruisheng Journal: Animal models and experimental medicine Issue: Volume 2:Issue 2(2019) Page Start: 107 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. ETS-1 induces Sorafenib-resistance in hepatocellular carcinoma cells via regulating transcription factor activity of PXR. (September 2018) Authors: Shao, Zhiyi; Li, Yibo; Dai, Wenjie; Jia, Hui; Zhang, Yingshi; Jiang, Qiyu; Chai, Yantao; Li, Xiaojuan; Sun, Huiwei; Yang, Ruichuang; Cao, Yu; Feng, Fan; Guo, Yingjie Journal: Pharmacological research Issue: Volume 135(2018) Page Start: 188 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. Which is the best combination of TACE and Sorafenib for advanced hepatocellular carcinoma treatment? A systematic review and network meta-analysis. (September 2018) Authors: Feng, Fan; Jiang, Qiyu; Jia, Hui; Sun, Huiwei; Chai, Yantao; Li, Xiaojuan; Rong, Guanghua; Zhang, Yingshi; Li, Zhengping Journal: Pharmacological research Issue: Volume 135(2018) Page Start: 89 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗